The Latest Analyst Ratings for Cross Country Healthcare
Portfolio Pulse from Benzinga Insights
Cross Country Healthcare (NASDAQ:CCRN) received mixed analyst ratings in the last quarter with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 4 analysts is $25.25, with a high of $32.00 and a low of $21.00. This target is a 19.84% decrease from the previous target of $31.50. Analysts provide these ratings by researching company financials, attending calls and meetings, and speaking with insiders.
November 29, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare's average analyst price target has been lowered to $25.25, indicating a negative sentiment shift among analysts.
The decrease in the average price target for CCRN suggests that analysts are less optimistic about the stock's future performance. This could lead to a negative short-term impact on the stock price as market participants digest the revised expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100